Avro Life Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Avro Life Sciences's estimated annual revenue is currently $4M per year.
- Avro Life Sciences's estimated revenue per employee is $155,000
Employee Data
- Avro Life Sciences has 26 Employees.
- Avro Life Sciences grew their employee count by -7% last year.
Avro Life Sciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder, COO | Reveal Email/Phone |
2 | Scientist | Reveal Email/Phone |
3 | Research Associate | Reveal Email/Phone |
4 | Scientist I | Reveal Email/Phone |
5 | Senior Scientist and Consultant | Reveal Email/Phone |
Avro Life Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.2M | 27 | 29% | $5M | N/A |
#2 | $1.7M | 11 | 22% | N/A | N/A |
#3 | $0.9M | 11 | -72% | $39.4M | N/A |
#4 | $1M | 13 | -84% | $23.8M | N/A |
#5 | $94.4M | 609 | 8% | N/A | N/A |
#6 | $3.4M | 22 | 10% | N/A | N/A |
#7 | $9.5M | 61 | -68% | N/A | N/A |
#8 | $18.1M | 117 | 30% | N/A | N/A |
#9 | $21.7M | 140 | -6% | N/A | N/A |
#10 | $1M | 13 | -41% | N/A | N/A |
What Is Avro Life Sciences?
Medical device/biopharmaceutical startup developing medicated stickers capable of delivering antihistamines and other small molecules to children. Target markets: Children, elderly, bariatric patients, dysphagia sufferers Part of the Velocity Incubator, Communitech network, and Bayer Grants4Apps accelerator
keywords:N/AN/A
Total Funding
26
Number of Employees
$4M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Avro Life Sciences News
2022-04-13 - Global Bioinformatics Market Analysis 2022-2026: A $21.32 ...
... Sparse Vector, Avro, Parquet and ORC (Optimized Row Compressed). ... Tripos; LP; Helicos Biosciences Incorporation; IBM Life Sciences.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4M | 27 | 13% | N/A |
#2 | $4.2M | 27 | 4% | N/A |
#3 | $6.2M | 27 | -10% | N/A |
#4 | $9.4M | 28 | 40% | N/A |
#5 | $4.3M | 28 | -10% | N/A |